Athersys Continues Rally

Shares of Athersys Inc. (Nasdaq: ATHX) continued to rally by leaping $2.72 to $5.12 following an analyst upgrade for its partnership with Pfizer Inc. (NYSE: PFE) to develop stem cell treatments. Pfizer stock edged up 2 cents to $18.63.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.